The investigators hypothesize that in addition to a known sympatholytic effect,
intraoperative dexmedetomidine reduces adverse changes in mitochondrial function and
structure attenuating ischaemia-reperfusion and end-organ injury for children with non
cyanotic congenital heart defects having corrective heart surgery.